Bnp Paribas Asset Management Holding S.A. Eli Lilly & CO Transaction History

Bnp Paribas Asset Management Holding S.A.

$37.6 Billion
Q1 2024

A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Eli Lilly & CO stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 697,891 shares of LLY stock, worth $632 Million. This represents 1.44% of its overall portfolio holdings.

Number of Shares

697,891

Previous 745,870 6.43%

Holding current value

$632 Million

Previous $435 Million 24.87%

% of portfolio

1.44%

Previous 1.21%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$592.2 - $792.28 $28.4 Million - $38 Million	-47,979 Reduced 6.43%	697,891 $543 Million
Q4 2023 Feb 09, 2024	SELL	$525.19 - $619.13 $69 Million - $81.3 Million	-131,385 Reduced 14.98%	745,870 $435 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $85.2 Million - $117 Million	195,977 Added 28.77%	877,255 $471 Million
Q2 2023 Aug 08, 2023	BUY	$350.74 - $468.98 $21.9 Million - $29.3 Million	62,507 Added 10.1%	681,278 $320 Million
Q1 2023 May 08, 2023	SELL	$310.63 - $364.82 $40.4 Million - $47.4 Million	-129,903 Reduced 17.35%	618,771 $212 Million

Q4 2022 Feb 09, 2023	BUY	$321.55 - $374.67 $35.2 Million - $41.1 Million	109,601 Added 17.15%	748,674 $274 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $40.2 Million - $45.8 Million	-135,605 Reduced 17.5%	639,073 $207 Million
Q2 2022 Aug 04, 2022	BUY	$278.73 - $327.27 $2.86 Million - $3.36 Million	10,275 Added 1.34%	774,678 $251 Million
Q1 2022 May 12, 2022	SELL	$234.69 - $291.66 $3.68 Million - $4.57 Million	-15,681 Reduced 2.01%	764,403 $219 Million
Q4 2021 Feb 09, 2022	BUY	$224.85 - $279.04 $16.5 Million - $20.5 Million	73,333 Added 10.38%	780,084 $215 Million
Q3 2021 Nov 08, 2021	BUY	$221.6 - $272.71 $17.3 Million - $21.3 Million	78,008 Added 12.41%	706,751 $163 Million
Q2 2021 Aug 05, 2021	SELL	$180.55 - $233.54 $11.2 Million - $14.5 Million	-62,284 Reduced 9.01%	628,743 $144 Million
Q1 2021 May 05, 2021	BUY	$164.32 - $212.72 $3.08 Million - $3.99 Million	18,760 Added 2.79%	691,027 $129 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $10.2 Million - $13.4 Million	77,879 Added 13.1%	672,267 $114 Million
Q3 2020 Nov 09, 2020	BUY	$146.22 - $169.13 $37 Million - $42.8 Million	252,955 Added 74.09%	594,388 $88 Million
Q2 2020 Aug 04, 2020	BUY	$136.42 - $164.18 $8.29 Million - $9.97 Million	60,734 Added 21.64%	341,433 $56.1 Million
Q1 2020 May 12, 2020	BUY	$119.05 - $147.35 $14.3 Million - $17.7 Million	120,005 Added 74.68%	280,699 $38.9 Million
Q4 2019 Feb 11, 2020	SELL	$106.92 - $132.43 $20.5 Million - $25.4 Million	-191,871 Reduced 54.42%	160,694 $21.1 Million
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $5.29 Million - $5.75 Million	49,529 Added 16.34%	352,565 $39.4 Million
Q2 2019 Aug 02, 2019	BUY	$110.79 - $129.32 $10.8 Million - $12.6 Million	97,399 Added 47.36%	303,036 $33.6 Million
Q1 2019 Apr 26, 2019	BUY	$111.31 - $131.02 $417,078 - $490,931	3,747 Added 1.86%	205,637 $26.7 Million
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $1.08 Million - $1.21 Million	10,192 Added 5.32%	201,890 $23.1 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $517,306 - $646,542	-6,025 Reduced 3.05%	191,698 $20.6 Million
Q2 2018 Aug 01, 2018	BUY	$75.7 - $86.88 $40,878 - $46,915	540 Added 0.27%	197,723 $16.9 Million
Q1 2018 May 07, 2018	SELL	$74.21 - $87.6 $4.67 Million - $5.51 Million	-62,937 Reduced 24.2%	197,183 $15.3 Million
Q4 2017 Feb 01, 2018	SELL	$81.94 - $87.89 $20 Million - $21.5 Million	-244,592 Reduced 48.46%	260,120 $22 Million
Q3 2017 Nov 02, 2017	BUY	$77.07 - $85.54 $38.9 Million - $43.2 Million	504,712	504,712 $43.2 Million

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.

Account

Bnp Paribas Asset Management Holding S.A. Eli Lilly & CO Transaction History